XOMA Limited (NASDAQ:XOMA)
CAPS Rating:
A biopharmaceutical company that discovers, develops and manufactures antibodies and other genetically-engineered protein products to treat immunological and inflammatory disorders, cancer and infectious diseases.
RSS Headlines
Fool UK
Recs
Nov 7 CC: top line data from EYEGUARD-A study at the end of 2013.
I can wait a year.